printer friendly pageMED 219: Navigating the Housing Crisis & Catalyzing Community-Driven Solutions
Students completing this course will walk away with a profound understanding of how to foster sustainable community partnerships. Through a combination of classroom instruction and service learning, students will develop an understanding of the complex causes and consequences of housing inequity, community-based case management, and community-driven solutions to the housing crisis. The course will emphasize the importance of centering the lived experiences of people who are unhoused and strategies for connecting them with essential resources that improve their health/well-being. Ultimately, the insight and experience students gain from the course will empower them to be a catalyst for housing equity in any corner of the world. This is a Cardinal Course certified by the Haas Center for Public Service.
Terms: Aut, Spr
| Units: 1-2
| Repeatable
2 times
(up to 4 units total)
Instructors:
Chang, D. (PI)
;
Lee, D. (TA)
;
Mayer, M. (TA)
;
Menjivar, A. (TA)
;
Rodriguez, S. (TA)
;
Su, E. (TA)
MED 220: Bioethical Challenges of New Technology
How might we apply ideas from ethical theory to contemporary issues and debates in biotechnology? This course will provide critical encounters with some of the central topics in the field of bioethics, with an emphasis on new technologies. Controversies over genetic engineering, stem cell research, reproductive technologies, and genetic testing will provide an opportunity for you to critically assess arguments and evidence. We will begin with an overview of the field and the theoretical approaches to bioethics that have been derived from philosophy. You will then have the opportunity to engage in debate and learn how to identify underlying values and how to apply ideas from ethical theory to contemporary problems. Prerequisites: Must have active enrollment within the Master of Clinical Informatics Management program.
Terms: Aut, Win, Spr
| Units: 1
| Repeatable
6 times
(up to 6 units total)
Instructors:
Magnus, D. (PI)
MED 221: Translational Research and Applied Medicine (MED 121)
(Same as
MED 121; undergraduate students enroll in
MED 121) Open to graduate students and medical students, this course enables students to learn basic principles in the design, performance and analysis of translational medical research studies. The course includes both didactic seminars from experts in translational medicine as well as the opportunity to design and present a translational research project. Students enrolling for 3 units are paired with a TRAM translational research project and work as a team with TRAM trainees and faculty on a weekly basis, as arranged by the instructor, and present a final project update at the end of the quarter. MTRAM students must enroll for a letter grade.
Terms: Aut, Win, Spr
| Units: 2-3
| Repeatable
3 times
(up to 9 units total)
MED 222: You Can Make a Difference in Primary Care (MED 155)
This course is designed to give pre-clerkship students an overview of the amazing and rewarding field of Primary Care Medicine. You will meet multiple primary care clinicians, each with a different area of interest and practice. You will learn about their work and what they love about it, and gain exposure to the diverse range of careers in Primary Care and its specialties. There will be opportunities to ask questions and make connections with Primary Care faculty at Stanford and beyond. For the clinic shadowing opportunity, each student will be paired with a clinician in a Stanford Primary Care clinic. Undergraduate students interested in the clinical shadowing experience should submit this short interest survey:
https://stanfordmedicine.qualtrics.com/jfe/form/SV_5nLgG5cCmnNQVGS and register for 2 units. Undergraduates, please register for
MED 155 (1 or 2 units). MD/PA/Grad students please register for
MED 222 (1 unit). Registration options for Undergraduates: (a) 1 unit for just the lecture series or (b) 2 units for the lecture series + an optional clinic shadowing opportunity and overview of clinical medicine.
Terms: Spr
| Units: 1-2
| Repeatable
10 times
(up to 10 units total)
MED 223: Cardiovascular and Pulmonary Sciences Seminar
Weekly seminar series featuring cardiovascular research by faculty. This course is intended for medical students, graduate students, and advanced undergraduate students. On Tuesdays, students attend Frontiers in Cardiovascualr Science. On Thursdays, a faculty member will present to students their research, followed by Q&A session with the students.
Terms: Aut, Win
| Units: 2
| Repeatable
for credit
Instructors:
Huang, N. (PI)
;
Karakikes, I. (PI)
;
Spiekerkoetter, E. (PI)
;
de Jesus Perez, V. (PI)
MED 224: Social Entrepreneurship and Innovation Lab (SE Lab) - Human & Planetary Health (HRP 224, PUBLPOL 224)
Social Entrepreneurship and Innovation Lab (SE Lab) - Global & Planetary Health is a Collaboratory workshop for students/fellows to design and develop innovative social ventures addressing key challenges in health and the environment, especially in support of the UN Sustainable Development Goals (SDGs 2030). Your mandate in identifying problems and designing solutions is broad and flexible! SE Lab is open to students and fellows across Stanford and combines design thinking exercises, short lectures & case studies, workshops, small group teamwork, presentations, guest speakers, and faculty, practitioner and peer feedback to support you and your team in generating and developing ideas and projects that will change the world! Join SE Lab with an idea or simply the desire to join a team. Enrollment limited to 30.
Terms: Aut, Win
| Units: 1-4
| Repeatable
3 times
(up to 15 units total)
Instructors:
Bloom, G. (PI)
MED 225: Introduction to Drug Development: A Guide to Therapeutic Innovation
This course is designed for medical students, trainees, basic scientists, clinicians and clinician-scientists at Stanford to provide an educational and practical perspective on the essential issues in drug development. Using a blend of seminars and dynamic workshops, the curriculum is focused on educating the audience on all stages of drug development and related research and business processes - from discovery and translational science and how to launch new projects to analyzing data, communication and interpretation of results of clinical trials, regulatory issues and commercial considerations in product development. The emphasis will be on cardiovascular applications. Proposed seminar topics are attached and include How Drugs Are Discovered and Developed, Case Studies of the various challenges in Drug Development, Cardiac Safety, Moving a Compound through the Drug Development Process, and the FDA Advisory Committee Process.
http://med.stanford.edu/cvi/education/cvi-courses/med225.html
Terms: Spr
| Units: 1
| Repeatable
2 times
(up to 2 units total)
Instructors:
Rajadas, J. (PI)
;
Chun, H. (SI)
;
DiBattiste, P. (SI)
...
more instructors for MED 225 »
Instructors:
Rajadas, J. (PI)
;
Chun, H. (SI)
;
DiBattiste, P. (SI)
;
Fox, J. (SI)
;
Gold, A. (SI)
;
Mueller, A. (SI)
;
Sager, P. (SI)
MED 226: Practical Approaches to Global Health Research (EPI 237, INTLPOL 290)
(Formerly
IPS 290) How do you come up with an idea for a useful research project in a low resource setting? How do you develop a research question, prepare a concept note, and get your project funded? How do you manage personnel in the field, complex cultural situations, and unexpected problems? How do you create a sampling strategy, select a study design, and ensure ethical conduct with human subjects? This course takes students through the process of health research in under-resourced countries from the development of the initial research question and literature review to securing support and detailed planning for field work. Students progressively develop and receive weekly feedback on a concept note to support a funding proposal addressing a research question of their choosing. Aimed at graduate students interested in global health research, though students of all disciplines interested in practical methods for research are welcome. Undergraduates who have completed 85 units or more may enroll with instructor consent. Sign up for 1 unit credit to participate in class sessions or 3 units to both participate in classes and develop a concept note.
Terms: Aut
| Units: 1
Instructors:
Luby, S. (PI)
MED 227: Drug Development: Key Issues in Regulation, Benefit vs. Risk, and Commercialization
This course is intended for medical students, graduate students, trainees, basic scientists, clinicians, and clinician scientists at Stanford to provide an educational and practical perspective of drug development: its incredible potential as well its challenges. Using a blend of seminars, debates, and case study analyses, the curriculum is focused on educating the audience on key regulatory issues and commercial considerations in product development, with an emphasis on cardiovascular applications. Seminar topics will include "Introduction to Regulatory Processes", "FDA Advisory Committee Meetings and Risk/Benefit/Approval Decisions", "Phase 1 Cardiovascular Safety Assessments in Drug Discovery and Development", "Case Study: Vioxx (Cox2 inhibitor) and the Cardiovascular Risk Question", "The Era of Requiring Outcomes Studies for Diabetes Drug Development", "Interface of Al and Clinical Trial Design", "Key Statistical Issues in Drug Development", "Reasons Why Phase 3 Programs Fail", "Co
more »
This course is intended for medical students, graduate students, trainees, basic scientists, clinicians, and clinician scientists at Stanford to provide an educational and practical perspective of drug development: its incredible potential as well its challenges. Using a blend of seminars, debates, and case study analyses, the curriculum is focused on educating the audience on key regulatory issues and commercial considerations in product development, with an emphasis on cardiovascular applications. Seminar topics will include "Introduction to Regulatory Processes", "FDA Advisory Committee Meetings and Risk/Benefit/Approval Decisions", "Phase 1 Cardiovascular Safety Assessments in Drug Discovery and Development", "Case Study: Vioxx (Cox2 inhibitor) and the Cardiovascular Risk Question", "The Era of Requiring Outcomes Studies for Diabetes Drug Development", "Interface of Al and Clinical Trial Design", "Key Statistical Issues in Drug Development", "Reasons Why Phase 3 Programs Fail", "Commercial Considerations in Drug Development: Is there a Market?", and "Dissection of Presentations and Publications of Major Cardiovascular Trials", Drug Development: Key Issues in Regulation, Benefit vs. Risk, and Commercialization (
MED227) complements the course
MED225 - Drug Development: From a Concept to the Clinic offered in the Spring. Previous exposure to MED225 content is not necessary to participate in
MED227.
https://med.stanford.edu/cvi/education/cvi-courses/med227.html
Terms: Aut
| Units: 1
| Repeatable
2 times
(up to 2 units total)
Instructors:
Chun, H. (PI)
;
Mueller, A. (PI)
;
Rajadas, J. (PI)
;
DiBattiste, P. (SI)
;
Fox, J. (SI)
;
Gold, A. (SI)
;
Sager, P. (SI)
MED 228: Physicians and Social Responsibility
Social and political context of the roles of physicians and health professionals in social change; policy, advocacy, and shaping public attitudes. How physicians have influenced governmental policy on nuclear arms proliferation; environmental health concerns; physicians in government; activism through research; the effects of poverty on health; homelessness; and gun violence. Guest speakers from national and international NGOs.
Last offered: Autumn 2022
Filter Results: